CASE STUDY
Antibody-Drug Conjugates
Meet your method development and sample testing needs for payloads and biologics for all phases of drug development.
Access our 20+ years of ADC experience, including preclinical through FDA approval of LC/MS and LBA assays for payloads and biologics.
When a complex ADA assay failed at two prior CROs, the sponsor turned to BioAgilytix for help. See how we applied a novel approach to overcome target interference challenges on a tight deadline.
What You'll Learn:
- How BioAgilytix conducted the GCP study evaluating the drug for multiple indications.
- An in-depth overview of the innovative solution BioAgilytix created to overcome target interference challenges caused by dimerization.
- How the assay got back on track, and how this same solution can be applied to other studies, such as oncological programs.